The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases ...
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback